interferometric Nanoparticle Tracking Analysis

Bruker offers nanoparticle tracking systems that determine particle size and concentration using an interferometric measurement principle called iNTA. A single, label-free particle-by-particle measurement also provides optical contrast / refractive-index-related information for each tracked particle, making it especially relevant for complex EV, viral vector, LNP, and biological nanoparticle samples.

Label-Free        

Particle Characterization

Higher
sample throughput.
The integrated 18-well plate reader enables sequential measurement of multiple samples without manual sample exchange after every run. 
Sharper
size resolution.
Instead of viewing size distribution alone, iNTA connects size with optical contrast, making particle distributions easier to interpret in complex samples.
Better
particle information.
Create 2D particle plots with interferometric NTA and reveal different populations in your sample label-free. 
Stronger
population assignment.
Focus on the particles of interest by identifying targets and assigning respective critical attributes (e.g. concentration).

iNTA: A direct path to bioparticle size, concentration, and composition

Interferometric Nanoparticle Tracking Analysis (iNTA) provides fast, label‑free nanoparticle characterization for teams working on gene and cell therapy vectors, extracellular vesicles, and next‑generation delivery systems—offering immediate insights into critical quality attributes (CQAs) across AdV, EV, LNP, and more.

What is interferometric Nanoparticle Tracking?

Comparison: NTA vs. iNTA

 NTA
(darkfield)
iNTA
(interferometry)
Size Resolutiongoodvery good
Concentrationsingle populationmulti population
Particle Propertiessizesize + refractive index
Plate Readernoyes
Well Plate Format-18-well plate
Sample Volume250–1,000 µL50–100 µL
Sample Conservationlowhigh

Meet iNTApharma: interferometric Nanoparticle Tracking Analyzer

iNTApharma is Bruker’s interferometric Nanoparticle Tracking Analysis system for biological nanoparticle characterization.

It provides the core information researchers expect from NTA: particle-by-particle size measurement and particle concentration. But iNTApharma goes further by adding interferometric optical contrast for each tracked particle, creating a richer 2D view of nanoparticle samples. Instead of reporting size and total concentration alone, iNTApharma helps users inspect particle populations by size and optical contrast.

Label-free, particle by particle, iNTApharma supports Nanoparticle Tracking Analysis for biological nanoparticles including extracellular vesicles, exosomes, lipid nanoparticles, and viral vectors. In addition to particle size and concentration, iNTA adds optical contrast information for each tracked particle, supporting label-free, particle-by-particle analysis of complex and polydisperse samples.

Extracellular Vesicle Analysis with iNTA

EV preparations can contain co-isolated particles such as lipoproteins, protein aggregates, or other nanoparticle populations that may overlap with EVs by size. By adding the dimension of optical contrast, we can better understand these complex samples:

  • Label-free sample insights: Distinguish EV-related particle populations from co-isolates label-free using size and interferometric optical contrast.
  • Performance on a new level: Obtain unprecedented resolution for your EV size distributions on par with electron microscopy methods.
  • Saves you time and sample: iNTA supports repeated EV sample measurements with low sample volume, plate-based handling, and an automated 18-well workflow.

For EV researchers, iNTApharma extends counting and sizing with label-free particle population analysis and helps to answer which particle populations contribute to the measurement.

View each tracked particle by size and optical contrast, instead of relying only on one-dimensional size distributions.

EV Size, Concentration, and Subpopulation Analysis  

Community insights: iNTA discussed in EVClub

The EVClub is a venue for discussing research and published articles related to extracellular vesicles (EVs), often including discussions with the authors themselves. It serves as a platform for sharing ideas within a wider community of EV researchers. In this context, Jan Van Deun and Vahid Sandoghdar talked about this new technology in the 177th edition. 

"Interferometric Nanoparticle Tracking Analysis enables label-free discrimination of extracellular vesicles from large lipoproteins".

Related Publications on Extracellular Vesicles and iNTA

Employing high‑resolution interferometric Nanoparticle Tracking Analysis to investigate how freezing‑induced accelerated ageing enhances the homogeneity, stability, and reproducibility of red blood cell‑derived extracellular vesicles for biomaterial applications.

Learn more here:

Red blood cell‑derived extracellular vesicles as biomaterials: the opportunity of freezing‑induced accelerated aging

Paolini, L., Romano, M., Mangolini, V., Tassoni, S., Jiang, S., Mazzoldi, E. L., Musicò, A., Zendrini, A., Kashkanova, A., Sandoghdar, V., Berardi, A. C., Giliani, S. C., Bergese, P., Radeghieri, A.

Biomaterials Science, 14, 122–139, 2026

Applying interferometric Nanoparticle Tracking Analysis for label‑free differentiation and accurate quantification of extracellular vesicles in complex biological samples containing large lipoproteins.

Learn more here:

Label‑free discrimination of extracellular vesicles from large lipoproteins

Kashkanova, A. D., Blessing, M., Reischke, M., Baur, J.-O., Baur, A. S., Sandoghdar, V., Van Deun, J.

Journal of Extracellular Vesicles, 12(8), 2023

Applications of iNTA

Label-Free Discrimination of Extracellular Vesicles (EV)

This application note highlights how interferometric Nanoparticle Tracking Analysis (iNTA) achieves label-free discrimination of extracellular vesicles (EVs) from co-isolates like lipoproteins in complex biological fluids. It is a vital read for researchers seeking to bypass the limitations of traditional size-based separation and fluorescence labeling.

Quality Assessment of Adenoviral Vectors

This application note details how interferometric Nanoparticle Tracking Analysis (iNTA) provides high-resolution, label-free quality control for adenoviral vectors (AdV). It is essential for researchers needing to distinguish intact viruses from contaminants or empty capsids, a task challenging for conventional methods like DLS or NTA.

Recent Publications

Employing interferometric Nanoparticle Tracking Analysis (iNTA) to enable high‑precision, non‑invasive measurement of size and refractive index distributions in weakly scattering nanoparticles within complex and polydisperse liquid samples.

Learn more here:

Precision size and refractive index analysis of weakly scattering nanoparticles in polydispersions

Kashkanova, A. D., Blessing, M., Gemeinhardt, A., Soulat, D., Sandoghdar, V.

Nature Methods, 19(5), 586–593, 2022

Employing interferometric Nanoparticle Tracking Analysis (iNTA) to enable quantitative, calibration‑free measurements of nanoparticle concentrations in complex and polydisperse liquid mixtures.

Learn more here:

Measuring Concentration of Nanoparticles in Polydisperse Mixtures Using iNTA

Kashkanova, A. D., Albrecht, D., Küppers, M., Blessing, M., Sandoghdar, V.

ACS Nano, published online July 9, 2024

Get in touch with our iNTA experts

Directly talk to our application experts and learn how iNTA can support your work.

Thank you for contacting us

Thank you for your interest in our iNTA Pharma Nanoparticle Analyzer.

We will contact you shortly.

Your Bruker Optics Team